1. To explore the usefulness of Procalcitonin(PCT) assay in the diagnosis of late onset neonatal sepsis (LONS) 2. To compare the diagnostic usefulness of Procalcitonin with C -reactive protein(CRP) Methods: Infants ≥48 hours old and being investigated for LONS were recruited after informed consent. The sepsis episodes were categorised into 3 groups: True positive, True negative and Possible sepsis on the basis of clinical symptoms, results from blood culture or other sterile body fluids and raised CRP or thrombocytopenia.
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Results: A total of 219 sepsis episodes in 121 infants were evaluated. There were 79(36%) true positive, 68(31%) possible sepsis and 71(33%) true negative episodes of sepsis. The sensitivity and specificity were calculated for true positive versus true negative episodes; and the cut-off used for CRP and procalcitonin was 10 and 0.5 respectively. The sensitivity of procalcitonin and CRP was 68% and 56% respectively whereas the specificity was 60% and 85%.
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Conclusion: Procalcitonin is a useful marker of LONS. In this study, PCT is more sensitive but less specific than CRP in the diagnosis of late onset neonatal sepsis. PCT could be used as a useful adjuvant to CRP in the evaluation of late onset neonatal sepsis.
